New Anticoagulants for Stroke Prevention in Atrial Fibrillation
Published Online: Tuesday, January 14, 2014
Christian Ruff, MD, MPH, of Harvard Medical School, gives an overview of the anticoagulants currently available for prevention of stroke in patients with atrial fibrillation.
Researchers evaluated the risk of cardiovascular outcomes in atrial fibrillation patients with a history of falls.
An FDA report concludes that aspirin’s risks may outweigh its benefits in patients who do not have a history of cardiovascular problems.